Vaginal health test provides first-of-its-kind fertility insights

Women’s precision healthcare company Evvy is launching Fertility Insights within its flagship Vaginal Microbiome Test, which provides insights on the role of the vaginal microbiome in fertility.

The vaginal microbiome is the community of bacteria, fungi, and viruses that live in the vagina – and emerging research highlights its crucial role in reproductive health. An imbalance in the vaginal microbiome can increase inflammation and the risk of infection in the reproductive tract, creating a less hospitable environment for conception.

On the other hand, a microbiome dominated by protective bacteria, such as Lactobacillus crispatus, has been associated with improved fertility, successful implantation, and improved pregnancy outcomes.

Today, one-third of all infertility cases are diagnosed as “unexplained.” While research has long linked vaginal microbial imbalances to infertility, recurrent pregnancy loss, and preterm birth, in-depth vaginal microbiome testing had not been widely accessible.

Evvy is closing this gap by providing first-of-its-kind, fertility-specific insights to help individuals understand and optimise this crucial but often overlooked aspect of their reproductive health.

“The connection between the vaginal microbiome and fertility is one of the most exciting frontiers in reproductive health,” said Dr. Kate McLean, Chief Medical Officer at Evvy.

“We’ve seen compelling research linking specific vaginal bacteria to everything from embryo implantation to pregnancy loss – yet this crucial information wasn’t available to patients or providers in fertility care. By making these insights accessible, Evvy is bridging the gap between cutting-edge science and real-world clinical impact, giving individuals and providers a new tool to support reproductive success.”

Evvy’s test result  now includes a new section for fertility insights including a measure of the levels of protective bacteria that are associated with positive outcomes, a measure of overall microbiome diversity, and levels of bacteria specifically associated with negative fertility outcomes, including Fannyhessea, Gardnerella, and Prevotella.

In addition to the insights, Evvy provides access to care protocols to optimise the vaginal microbiome through personalised prescription treatments, lifestyle recommendations, and 1:1 health coaching.

“For too long, fertility has been treated like a black box leaving millions of people searching for answers with no clear path forward,” said Priyanka Jain, co-founder and CEO of Evvy.

“By expanding our Vaginal Microbiome Test to include fertility insights, we’re giving people the power to take control of their reproductive health with comprehensive testing and data-driven, personalised care.”